Go Back   SEQanswers > Sequencing Technologies/Companies > SOLiD

Similar Threads
Thread Thread Starter Forum Replies Last Post
stanford's machine learning applied in bioinformatics delinquentme Bioinformatics 6 11-23-2011 06:19 AM
PubMed: Next-generation sequencing applied to molecular diagnostics. Newsbot! Literature Watch 0 08-25-2011 11:10 AM
SOCS: Efficient mapping of Applied Biosystems SOLiD sequence data to a ref genome... ECO Literature Watch 0 10-20-2008 08:53 PM
Mobious Biosystems: A new player in the third-gen space uncloaks.... genseq The Pipeline 3 10-09-2008 05:00 PM
In Sequence: Illumina, Avantome, Roche, 454 Life Sciences, Applied Biosystems, InteRN Newsbot! Illumina/Solexa 0 07-22-2008 02:06 PM

Thread Tools
Old 06-12-2008, 09:48 AM   #1
--Site Admin--
Location: SF Bay Area, CA, USA

Join Date: Oct 2007
Posts: 1,358
Default Invitrogen to Acquire Applied Biosystems for $6.7B


Big news today. Invitrogen acquires ABI.

From GenomeWeb:

NEW YORK (GenomeWeb News) Ė Invitrogen and Applied Biosystems announced today that Invitrogen will acquire all of the outstanding shares of ABI in a cash and stock deal valued at $6.7 billion.

The acquisition combines Invitrogenís portfolio of reagents and low-cost instruments focused on the molecular and cell biology and protein research markets with ABIís vast array of consumables and instruments for applications such as DNA sequencing, proteomics, RNAi, gene expression, and applied testing.

The combined company, which will retain the Applied Biosystems name but will be based at Invitrogenís headquarters in Carlsbad, Calif., will have approximately $3.5 billion in revenue, of which roughly 70 percent will come from consumables and services.

Invitrogen Chairman and CEO Greg Lucier and ABI President and COO Mark Stevenson will hold the same roles in the combined company. The board of directors will include nine current Invitrogen board members and three ABI board members, though the firms did not disclose the names of those directors.

The combined firm will boast a sales and service force of approximately 3,000 employees and have customers in more than 100 countries.

Under terms of the deal, ABI shareholders will receive $38 for each share they own in the form of Invitrogen stock and cash, with cash accounting for 45 percent of the split. The purchase price represents a 12 percent premium to ABIís average closing price for the previous 30 trading days.

The firms expect the transaction to close in the fall, pending regulatory and shareholder approval.
ECO is offline   Reply With Quote
Old 06-17-2008, 05:16 PM   #2
--Site Admin--
Location: SF Bay Area, CA, USA

Join Date: Oct 2007
Posts: 1,358

Another article with more details at In Sequence
ECO is offline   Reply With Quote
Old 06-20-2008, 08:08 AM   #3
Junior Member
Location: Maryland, D.C. Suburbs

Join Date: Jun 2008
Posts: 1
Default re: ABI

To quote Mr. T.........

I pity the poor fools...(at ABI)

rmervis is offline   Reply With Quote
Old 06-20-2008, 04:10 PM   #4
Junior Member
Location: San Diego

Join Date: Oct 2007
Posts: 4
Default Free special report on ABI and invitrogen merger from BioInformatics, LLC

free Special Report exclusively for Applied Biosystems and Invitrogen and the results can be downloaded HYPERLINK
Digi is offline   Reply With Quote

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

All times are GMT -8. The time now is 01:49 PM.

Powered by vBulletin® Version 3.8.9
Copyright ©2000 - 2021, vBulletin Solutions, Inc.
Single Sign On provided by vBSSO